Daclatasvir Impurity F

Product Name: Daclatasvir Impurity F
CAS No.: 1007884-60-7
Chemical Name: Daclatasvir Impurity F
Synonyms: Daclatasvir Impurity 40;Monodes(N-carboxymethyl)valine Daclatasvir;methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-{5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]butan-2-yl]carbamate;Methyl ((S)-3-methyl-1-oxo-1-((S)-2-(5-(4''-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)butan-2-yl)carbamate;Carbamic acid, N-[(1S)-2-methyl-1-[[(2S)-2-[5-[4'-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]-, methyl ester;Daclatasvir impurity 14/Monodes(N-carboxymethyl)valine Daclatasvir/N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4’-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester
CBNumber: CB03154294
Molecular Formula: C33H39N7O3
Formula Weight: 581.71
MOL File: 1007884-60-7.mol

More

Less

Daclatasvir Impurity F Property

Boiling point:: 963.0±65.0 °C(Predicted)
Density: 1.239±0.06 g/cm3(Predicted)
storage temp.: Store at -20°C
form: Solid
pka: 11.22±0.46(Predicted)
color: White to off-white

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

TRC

Product number: M537990
Product name: Monodes(N-carboxymethyl)valineDaclatasvir
Packaging: 1mg
Price: $75
Updated: 2021/12/16

ChemScene

Product number: CS-0116105
Product name: Monodes(N-carboxymethyl)valineDaclatasvir
Packaging: 5mg
Price: $400
Updated: 2021/12/16

ChemScene

Product number: CS-0116105
Product name: Monodes(N-carboxymethyl)valineDaclatasvir
Packaging: 10mg
Price: $680
Updated: 2021/12/16

More

Less

Daclatasvir Impurity F Chemical Properties,Usage,Production

Uses

Monodes(N-carboxymethyl)valine Daclatasvir is an impurity of Daclatasvir (D101500); a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV).

Daclatasvir Impurity F Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Daclatasvir Impurity F Suppliers

China 21 India 4 United Kingdom 1 United States 5 Global 31

Standardpharm Co. Ltd.

Tel: 86-714-3992388
Email: overseasales1@yongstandards.com
Country: United States
ProdList: 14332
Advantage: 58

BOC Sciences

Tel: +1-631-485-4226
Fax: 1-631-614-7828
Email: inquiry@bocsci.com
Country: United States
ProdList: 19553
Advantage: 58

Cato Research Chemicals Inc.

Tel: 020-81215950 4000-868-328
Email: customer@uwalab.com
Country: United States
ProdList: 10404
Advantage: 58

United States Biological

Tel: --
Fax: --
Email: chemicals@usbio.net
Country: United States
ProdList: 6214
Advantage: 80

MedChemExpress

Tel: --
Fax: --
Email: sales@medchemexpress.com
Country: United States
ProdList: 6398
Advantage: 58

1007884-60-7, Daclatasvir Impurity FRelated Search:

Daclatasvir Impurity Daclatasvir Impurity 1 1,1'-[1,1'-biphenyl]-4,4'-diylbis[2,2-dibromo]-ethanone Daclatasvir Impurity 7 Daclatasvir Dihydrochloride methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate 1-{4'-acetyl-[1,1'-biphenyl]-4-yl}-2-bromoethan-1-one Daclatasvir Impurity 5 (SRSS-Isomer)

Monodes(N-carboxymethyl)valine Daclatasvir

Daclatasvir impurity 14/Monodes(N-carboxymethyl)valine Daclatasvir/N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4’-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester

methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-{5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]butan-2-yl]carbamate

Daclatasvir Impurity 40

Methyl ((S)-3-methyl-1-oxo-1-((S)-2-(5-(4''-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)butan-2-yl)carbamate

Carbamic acid, N-[(1S)-2-methyl-1-[[(2S)-2-[5-[4'-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]-, methyl ester

1007884-60-7

C33H39N7O3